Merck’s slides weighs on drug stocks

The drug sector keys on Merck’s fourth-quarter loss and a disappointing profit outlook.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.